Related references
Note: Only part of the references are listed.OncoLoop: A Network-Based Precision Cancer Medicine Framework
Alessandro Vasciaveo et al.
CANCER DISCOVERY (2023)
Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer
Tizita Z. Zeleke et al.
NATURE CANCER (2023)
A modular master regulator landscape controls cancer transcriptional identity
Evan O. Paull et al.
CELL (2021)
An expanded universe of cancer targets
William C. Hahn et al.
CELL (2021)
Uniform genomic data analysis in the NCI Genomic Data Commons
Zhenyu Zhang et al.
NATURE COMMUNICATIONS (2021)
Translational Strategies for Repotrectinib in Neuroblastoma
Tara J. O'Donohue et al.
MOLECULAR CANCER THERAPEUTICS (2021)
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
Lei Zhong et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages
Aleksandar Obradovic et al.
CELL (2021)
Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of Glioblastoma
Rachael A. Vaubel et al.
CLINICAL CANCER RESEARCH (2020)
Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 Study
Najat C. Daw et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Establishment of patient-derived xenografts from patients with gastrointestinal stromal tumors: analysis of clinicopathological characteristics related to engraftment success
Young-Soon Na et al.
SCIENTIFIC REPORTS (2020)
Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models of Primary and Recurrent Meningioma
Huiyuan Zhang et al.
CANCERS (2020)
Molecular principles of metastasis: a hallmark of cancer revisited
Jawad Fares et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Calcifying Nested Stromal-Epithelial Tumor of the Liver An Update and Literature Review
Mark Benedict et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2019)
Adaptive Resistance to Dual BRAF/MEK Inhibition in BRAF-Driven Tumors through Autocrine FGFR Pathway Activation
Victoria E. Wang et al.
CLINICAL CANCER RESEARCH (2019)
Reply to 'H-STS, L-STS and KRJ-I are not authentic GEPNET cell lines'
Mariano J. Alvarez et al.
NATURE GENETICS (2019)
Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study
David B. Dix et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors
Mariano J. Alvarez et al.
NATURE GENETICS (2018)
Quantitative assessment of protein activity in orphan tissues and single cells using the metaVIPER algorithm
Hongxu Ding et al.
NATURE COMMUNICATIONS (2018)
Cross-Cohort Analysis Identifies a TEAD4-MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma
Presha Rajbhandari et al.
CANCER DISCOVERY (2018)
Differentiation-state plasticity is a targetable resistance mechanism in basal-like breast cancer
Tyler Risom et al.
NATURE COMMUNICATIONS (2018)
Trends in the global immuno-oncology landscape
Jun Tang et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Drug and disease signature integration identifies synergistic combinations in glioblastoma
Vasileios Stathias et al.
NATURE COMMUNICATIONS (2018)
Calcifying nested stromal-epithelial tumor (CNSET) of the liver in Beckwith-Wiedemann syndrome
Nasim Khoshnam et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2017)
Patient-derived xenografts undergo mouse-specific tumor evolution
Uri Ben-David et al.
NATURE GENETICS (2017)
Successful liver transplantation for non-resectable desmoplastic nested spindle cell tumor complicated by Cushing's syndrome
Sarah Tehseen et al.
PEDIATRIC TRANSPLANTATION (2017)
PLATE-Seq for genome-wide regulatory network analysis of high-throughput screens
Erin C. Bush et al.
NATURE COMMUNICATIONS (2017)
Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer
Min Zou et al.
CANCER DISCOVERY (2017)
The recurrent architecture of tumour initiation, progression and drug sensitivity
Andrea Califano et al.
NATURE REVIEWS CANCER (2017)
Elucidation and Pharmacological Targeting of Novel Molecular Drivers of Follicular Lymphoma Progression
Brygida Bisikirska et al.
CANCER RESEARCH (2016)
Reproducible pharmacogenomic profiling of cancer cell line panels
Peter M. Haverty et al.
NATURE (2016)
Functional characterization of somatic mutations in cancer using network-based inference of protein activity
Mariano J. Alvarez et al.
NATURE GENETICS (2016)
Limits to Personalized Cancer Medicine
Ian F. Tannock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Elucidating Compound Mechanism of Action by Network Perturbation Analysis
Jung Hoon Woo et al.
CELL (2015)
Inhibition of the autocrine IL-6-JAK2-STAT3-calprotectin axis as targeted therapy for HR-/HER2(+) breast cancers
Ruth Rodriguez-Barrueco et al.
GENES & DEVELOPMENT (2015)
Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT) A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology
Donavan T. Cheng et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2015)
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial
Christophe Le Tourneau et al.
LANCET ONCOLOGY (2015)
Cross-Species Regulatory Network Analysis Identifies a Synergistic Interaction between FOXM1 and CENPF that Drives Prostate Cancer Malignancy
Alvaro Aytes et al.
CANCER CELL (2014)
Identification of Causal Genetic Drivers of Human Disease through Systems-Level Analysis of Regulatory Networks
James C. Chen et al.
CELL (2014)
A community computational challenge to predict the activity of pairs of compounds
Mukesh Bansal et al.
NATURE BIOTECHNOLOGY (2014)
Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
Manuel Hidalgo et al.
CANCER DISCOVERY (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Direct Reversal of Glucocorticoid Resistance by AKT Inhibition in Acute Lymphoblastic Leukemia
Erich Piovan et al.
CANCER CELL (2013)
A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
Xiaomei Zhang et al.
CANCER RESEARCH (2013)
Subcutaneous tumor volume measurement in the awake, manually restrained mouse using MRI
Veerle Kersemans et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2013)
The Genotype-Tissue Expression (GTEx) project
John Lonsdale et al.
NATURE GENETICS (2013)
β-Catenin mutations in 2 nested stromal epithelial tumors of the liver-a neoplasia with defective mesenchymalepithelial transition
Gerald Assmann et al.
HUMAN PATHOLOGY (2012)
When Progressive Disease Does Not Mean Treatment Failure: Reconsidering the Criteria for Progression
Geoffrey R. Oxnard et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
A Validated Tumorgraft Model Reveals Activity of Dovitinib Against Renal Cell Carcinoma
S. Sivanand et al.
Science Translational Medicine (2012)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
The transcriptional network for mesenchymal transformation of brain tumours
Maria Stella Carro et al.
NATURE (2010)
Interval approach to assessing antitumor activity for tumor xenograft studies
Jianrong Wu et al.
PHARMACEUTICAL STATISTICS (2010)
Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice
Michael P. Kim et al.
NATURE PROTOCOLS (2009)
Establishment of Patient-Derived Non-Small Cell Lung Cancer Xenografts as Models for the Identification of Predictive Biomarkers
Iduna Fichtner et al.
CLINICAL CANCER RESEARCH (2008)
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors
Jason I. Herschkowitz et al.
GENOME BIOLOGY (2007)
ARACNE: An algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context
AA Margolin et al.
BMC BIOINFORMATICS (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Reverse engineering of regulatory networks in human B cells
K Basso et al.
NATURE GENETICS (2005)
Nested stromal epithelial tumor of the liver - Six cases of a distinctive pediatric neoplasm with frequent calcifications and association with Cushing syndrome
A Heerema-Mckenney et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Two-sample tests for growth curves under dependent right censoring
Y Vardi et al.
BIOMETRIKA (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
